For the quarter ending 2025-09-30, UTMD made $9,812K in revenue. $2,255K in net income. Net profit margin of 22.98%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Sales, net | 9,812 | 9,953 | 9,710 | 12,802* |
| Cost of goods sold | 4,208 | 4,358 | 4,172 | 4,235* |
| Gross profit | 5,604 | 5,595 | 5,538 | 8,567* |
| Sales and marketing | - | - | - | 475* |
| Selling, general and administrative | 2,826 | 2,264 | 2,231 | - |
| Research & development | 167 | 135 | 154 | 173* |
| General and administrative | - | - | - | 1,959* |
| Total operating expense | 2,993 | 2,399 | 2,385 | - |
| Operating income | 2,611 | 3,196 | 3,153 | 5,960* |
| Royalty income (note 12) | - | - | - | 4* |
| Other income | 698 | 640 | 705 | -2,587* |
| Dividend and interest income | - | - | - | 842* |
| Income before provision for income taxes | 3,309 | 3,836 | 3,858 | 4,218* |
| Provision for income taxes | 678 | 788 | 817 | 867* |
| Net income | 2,631 | 3,048 | 3,041 | 3,351* |
| Foreign currency translation net of taxes of 0 in all periods | -376 | 1,828 | 718 | -3,347* |
| Total comprehensive income | 2,255 | 4,876 | 3,759 | 3 |
| Basic EPS | 0.82 | 0.94 | 0.92 | 0.001 |
| Diluted EPS | 0.82 | 0.94 | 0.92 | 0.001 |
| Basic Average Shares | 3,207,000 | 3,246,000 | 3,310,000 | 3,499,000 |
| Diluted Average Shares | 3,207,000 | 3,246,000 | 3,310,000 | 3,499,000 |
UTAH MEDICAL PRODUCTS INC (UTMD)
UTAH MEDICAL PRODUCTS INC (UTMD)